
Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.
Close

Research

Featured research

C-section pain management study thumbnail image in Truveta branding.

Pain management after C-section: Following the journey from hospital to home

Pain medication use was nearly universal in the hospital, with more than 9 in 10 C-sections including acetaminophen, an NSAID, and an opioid. After discharge, NSAIDs and opioids were prescribed after about 6 in 10 C-sections and acetaminophen after about half. The...
Read More
Rising rate of non-receipt of vitamin K for newborns, January 2019–June 2026

Rising rate of non-receipt of vitamin K for newborns, 2019–June 2026

Truveta Research finds documented newborn vitamin K non-receipt rose from 5.2% in January to 8.1% in June 2026, continuing a recent upward trend.

Read More
Graphic from Truveta showing a record increase in GLP-1 prescribing among older adults following the launch of Medicare's GLP-1 Bridge program, with trend lines illustrating prescribing growth over time.

Older adults see record increase in GLP-1 prescribing following Medicare GLP-1 Bridge program

New Truveta research shows GLP-1 prescribing among adults 65+ rose 19% in July 2026, a record increase after Medicare’s GLP-1 Bridge launch.

Read More
Truveta research graphic titled '2026 Cyclosporiasis Outbreak: Diagnoses Reach Historic Levels,' featuring outbreak trend lines that illustrate a significant rise in cyclospora diagnoses during summer 2026

Cyclosporiasis diagnoses reach historic levels in 2026 summer outbreak

Real-world data reveal record cyclosporiasis diagnoses during the 2026 summer outbreak and support faster outbreak monitoring.

Read More

Featured research topics

GLP-1

Oncology

Flu/RSV

Measles

Cardiovascular